Open-Label Study to Determine How Prior Therapy with Alendronate or Risedronate in Postmenopausal Women with Osteoperosis Influences the Clinical Effectiveness of Teriparatide (OPTAMISE Study)

The PI of this project was:

This project was funded by: Aventis Pharmaceuticals

The term of this project was: June 2004 to October 2006

The number of subjects scanned during this project was: 12